PET/MR Imaging In Patients With Cardiac Sarcoidosis

Status Completed

Clinical Trial Summary

PET scanning (positron emission tomography) is a well-established technique used to identify areas of interest within the body. It involves injecting a radioactive tracer which highlights abnormal areas. It has recently been combined with CT (computed tomography) and MRI (magnetic resonance imaging) scanning to more accurately identify abnormalities within the heart. Cardiac sarcoidosis, a condition which causes scarring and inflammation within the heart muscle, is of particular interest. The study makes use of hybrid PET/MR scanning using a designated scanner which enables PET scanning combined with MRI scanning. This will allow imaging of abnormal areas within the heart in this condition alongside treatment regimens in a way which hasn't been done before. If successful, this imaging method will play a key role in diagnosing, quantifying and monitoring these conditions. All participants will undergo PET scanning, where a radioactive tracer is injected into a vein before the scan. The radioactive substance only lasts for a short time and is safe, passed out of the body in urine. The scan will be performed twice; once before treatment and once after treatment has been established. A cohort of healthy volunteers will undergo scanning in exactly the same way to enable us to compare the results with hearts of people who don't have cardiac sarcoidosis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03705884
Study type	Interventional
Source	University of Edinburgh
Contact
Status	Completed
Phase	N/A
Start date	October 30, 2017
Completion date	December 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04017936` - Interleukin-1 Blockade for Treatment of Cardiac Sarcoidosis	Phase 2
Recruiting	`NCT06131112` - Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis
Terminated	`NCT03923049` - Feasibility and Accuracy of Hybrid Magnetic Resonance and Positron Emission Tomography With 18F-Fluorodeoxyglucose in Diagnosing Cardiac Sarcoidosis	N/A
Not yet recruiting	`NCT05954507` - Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis	N/A
Recruiting	`NCT06409585` - Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Recruiting	`NCT04737317` - Diagnostic Criteria in Cardiac Sarcoidosis
Recruiting	`NCT03057002` - UTSW HP [13-C] Pyruvate Injection in HCM
Completed	`NCT03599414` - CASPA: CArdiac Sarcoidosis in PApworth
Withdrawn	`NCT02812849` - Somatostatin Receptor Imaging in Cardiac Sarcoidosis
Completed	`NCT01729169` - Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET	N/A
Completed	`NCT03549598` - d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis	Phase 4
Recruiting	`NCT04758650` - Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis	Phase 2
Recruiting	`NCT04206163` - Somatostatin Receptor Imaging in Acute Myocarditis and Cardiac Sarcoidosis	N/A
Recruiting	`NCT05499637` - [68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation	Phase 2
Recruiting	`NCT03593759` - Cardiac Sarcoidosis Randomized Trial	Phase 3
Recruiting	`NCT05145023` - Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis
Enrolling by invitation	`NCT04774549` - Inflammatory Cardiomyopathy Bern Registry
Recruiting	`NCT03049254` - Mayo AVC Registry and Biobank
Completed	`NCT03746847` - PET Imaging in Patients With Suspected Cardiac Sarcoidosis
Recruiting	`NCT01477359` - Cardiac Sarcoidosis Multi-Center Prospective Cohort